REED JOHN C

REED JOHN C, EVP, Innovative Medicine, R&D, has filed 4 insider trading reports covering 1 company. Total disclosed trading volume is $58.3M. Sales ($20.4M) outpace purchases ($0) over this period. Insider sales are common for diversification and personal financial planning and should be evaluated with full context. The largest single filing involves JOHNSON & JOHNSON (JNJ). All transactions sourced from SEC Form 4 filings.